20 July 2026
METLEN Energy & Metals PLC
(the "Company")
Transaction in own shares
The Company announces that, in accordance with the terms of its share buyback programme announced on 23 June 2026, during the period from 13 July 2026 to 17 July 2026 (inclusive) (the "Disclosure Period"), it purchased the following number of its ordinary shares of €1.00 each through Piraeus Securities S.A.:
Date within Disclosure Period Trading Venue Aggregate number of ordinary shares repurchased Lowest price paid (per ordinary share, in euro) Highest price paid (per ordinary share, in euro) Volume-weighted average price (per ordinary share, in euro) | 13 July 2026 Euronext Athens 25.000 40,52 41,00 40,9039 | 14 July 2026 Euronext Athens 30.000 40,78 41,50 41,3396 | 15 July 2026 Euronext Athens 20.000 41,36 41,78 41,5610 | 16 July 2026 Euronext Athens 5.000 41,58 41,98 41,8784 | 17 July 2026 Euronext Athens 33.190 42,94 43,32 43,1028 |
These shares will be held in Treasury.
Following these transactions. the Company's share capital comprises:
Total issued share capital: 143.426.244
Shares held in treasury (with no voting rights): 383.958
Total voting rights: 143.042.286
For reporting purposes under the FCA's Disclosure Guidance and Transparency Rules the market should exclude any shares held in treasury and should use the figure of 143.042.286 as the denominator for the calculations when determining if they are required to notify their interest in. or a change to their interest in the Company.
LEI - 213800ZSR3HVKMMPVG86
For further information. please contact:
Investor Relations
Tel. +30 210-6877300 | Fax +30 210-6877400 | E-mail: [email protected]
Press Office
Tel. +30 210-6877346 | Fax +30 210-6877400 | E-mail: [email protected]
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END POSDBLBLQDLLBBK